Click here to view original web page at acsh.org
Credit: Shutterstock Early results from a phase II clinical trial shows promise for curbing postpartum depression (PPD), a rare but extreme mood disorder which affects new mothers. The bio-pharmaceutical company, Sage Therapeutics announced the early findings of the intravenous drug SAGE-547 last week. According to a 2013 publication in [...]
